Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 442

1.

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data.

Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, Hertzman C.

Birth Defects Res B Dev Reprod Toxicol. 2008 Feb;83(1):68-76. doi: 10.1002/bdrb.20144.

PMID:
18293409
[PubMed - indexed for MEDLINE]
2.

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Arch Gen Psychiatry. 2006 Aug;63(8):898-906.

PMID:
16894066
[PubMed - indexed for MEDLINE]
3.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
[PubMed - indexed for MEDLINE]
4.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
[PubMed - indexed for MEDLINE]
5.

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.

Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.

Br J Psychiatry. 2008 May;192(5):338-43. doi: 10.1192/bjp.bp.107.037101.

PMID:
18450656
[PubMed - indexed for MEDLINE]
Free Article
6.

Maternal smoking and congenital heart defects.

Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, Hobbs CA; National Birth Defects Prevention Study.

Pediatrics. 2008 Apr;121(4):e810-6. doi: 10.1542/peds.2007-1519.

PMID:
18381510
[PubMed - indexed for MEDLINE]
Free Article
7.

Birth outcomes after prenatal exposure to antidepressant medication.

Hendrick V, Smith LM, Suri R, Hwang S, Haynes D, Altshuler L.

Am J Obstet Gynecol. 2003 Mar;188(3):812-5.

PMID:
12634662
[PubMed - indexed for MEDLINE]
8.

[In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].

Bonnot O, Vollset SE, Godet PF, d'Amato T, Dalery J, Robert E.

Encephale. 2003 Nov-Dec;29(6):553-9. Review. French.

PMID:
15029090
[PubMed - indexed for MEDLINE]
9.

Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.

Pawluski JL, Galea LA, Brain U, Papsdorf M, Oberlander TF.

Pediatrics. 2009 Oct;124(4):e662-70. doi: 10.1542/peds.2009-0442. Epub 2009 Sep 28.

PMID:
19786426
[PubMed - indexed for MEDLINE]
Free Article
10.

Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.

Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM.

Mol Psychiatry. 2008 Jan;13(1):65-73. Epub 2007 May 22.

PMID:
17519929
[PubMed - indexed for MEDLINE]
11.

Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.

Rahimi R, Nikfar S, Abdollahi M.

Reprod Toxicol. 2006 Nov;22(4):571-5. Epub 2006 May 23. Review.

PMID:
16720091
[PubMed - indexed for MEDLINE]
12.

SSRI antidepressants and birth defects.

[No authors listed]

Prescrire Int. 2006 Dec;15(86):222-3.

PMID:
17167929
[PubMed - indexed for MEDLINE]
13.

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.

Källén BA, Otterblad Olausson P.

Birth Defects Res A Clin Mol Teratol. 2007 Apr;79(4):301-8.

PMID:
17216624
[PubMed - indexed for MEDLINE]
14.

Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.

Wikner BN, Stiller CO, Bergman U, Asker C, Källén B.

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1203-10.

PMID:
17894421
[PubMed - indexed for MEDLINE]
15.

Bupropion in pregnancy and the prevalence of congenital malformations.

Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):474-84.

PMID:
16897811
[PubMed - indexed for MEDLINE]
16.

First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

Bakker MK, Kerstjens-Frederikse WS, Buys CH, de Walle HE, de Jong-van den Berg LT.

Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):94-100. doi: 10.1002/bdra.20641.

PMID:
19937603
[PubMed - indexed for MEDLINE]
17.

Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.

Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W.

Pediatrics. 2005 Feb;115(2):411-25.

PMID:
15687451
[PubMed - indexed for MEDLINE]
18.

Maternal exposure to ambient air pollutants and risk of congenital anomalies.

Rankin J, Chadwick T, Natarajan M, Howel D, Pearce MS, Pless-Mulloli T.

Environ Res. 2009 Feb;109(2):181-7. doi: 10.1016/j.envres.2008.11.007. Epub 2009 Jan 8.

PMID:
19135190
[PubMed - indexed for MEDLINE]
19.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
[PubMed - indexed for MEDLINE]
20.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk